ALFA News
Straight from the exchange filing
Every announcement Emcure Pharmaceuticals has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Emcure Pharmaceuticals announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Emcure Pharmaceuticals reports FY26 revenue of ₹9,204 crore, achieving 16.6% YoY growth and surpassing the $1 billion mark with strong international performance.
Emcure Pharmaceuticals reports ₹9,204 Cr revenue for FY26, surpassing the $1 billion mark. Management guides for margin expansion and domestic recovery in FY27.
